Literature DB >> 33175520

Injectable Single-Component Peptide Depot: Autonomously Rechargeable Tumor Photosensitization for Repeated Photodynamic Therapy.

Hong-Jun Cho1, Sung-Jun Park1,2, Woo Hyuk Jung3, Yuri Cho1,4, Dong June Ahn3,4, Yoon-Sik Lee2, Sehoon Kim1,4.   

Abstract

The general practice of photodynamic therapy (PDT) comprises repeated multiple sessions, where photosensitizers are repeatedly administered prior to each operation of light irradiation. To address potential problems arising from the total overdose of photosensitizer by such repeated injections, we here introduce an internalizing RGD peptide (iRGD) derivative (Ppa-iRGDC-BK01) that self-aggregates into an injectable single-component supramolecular depot. Ppa-iRGDC-BK01 is designed as an in situ self-implantable photosensitizer so that it forms a depot by itself upon injection, and its molecular functions (cancer cell internalization and photosensitization) are activated by sustained release, tumor targeting, and tumor-selective proteolytic/reductive cleavage of the iRGD segment. The experimental and theoretical studies revealed that when exposed to body temperature, Ppa-iRGDC-BK01 undergoes thermally accelerated self-assembly to form a supramolecular depot through the hydrophobic interaction of the Ppa pendants and the reorganization of the interpeptide hydrogen bonding. It turned out that the self-aggregation of Ppa-iRGDC-BK01 into a depot exerts a multiple-quenching effect on the photosensitivity to effectively prevent nonspecific phototoxicity and protect it from photobleaching outside the tumor, while enabling autonomous tumor rephotosensitization by long sustained release, tumor accumulation, and intratumoral activation over time. We demonstrate that depot formation through a single peritumoral injection and subsequent quintuple laser irradiations at intervals resulted in complete eradication of the tumor. During the repeated PDT, depot-implanted normal tissues around the tumor exhibited no phototoxic damage under laser exposure. Our approach of single-component photosensitizing supramolecular depot, combined with a strategy of tumor-targeted therapeutic activation, would be a safer and more precise operation of PDT through a nonconventional protocol composed of one-time photosensitizer injection and multiple laser irradiations.

Entities:  

Keywords:  activatable photosensitizer; internalizing RGD (iRGD); molecular depot; photodynamic therapy; sustained release

Mesh:

Substances:

Year:  2020        PMID: 33175520     DOI: 10.1021/acsnano.0c06881

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  2 in total

1.  Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy.

Authors:  Gang He; Yashi Li; Muhammad Rizwan Younis; Lian-Hua Fu; Ting He; Shan Lei; Jing Lin; Peng Huang
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

2.  Asymmetric, amphiphilic RGD conjugated phthalocyanine for targeted photodynamic therapy of triple negative breast cancer.

Authors:  Rui Li; Yiming Zhou; Yijia Liu; Xingpeng Jiang; Wenlong Zeng; Zhuoran Gong; Gang Zheng; Desheng Sun; Zhifei Dai
Journal:  Signal Transduct Target Ther       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.